Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Divestments (2017 - 2019)

Medicure has reported Divestments over the past 6 years, most recently at $5.1 million for Q4 2019.

  • For Q4 2019, Divestments changed N/A year-over-year to $5.1 million; the TTM value through Dec 2019 reached $25.6 million, down 50.46%, while the annual FY2024 figure was -$529012.5, 164.35% down from the prior year.
  • Divestments for Q4 2019 was $5.1 million at Medicure, up from -$5.0 million in the prior quarter.
  • Over five years, Divestments peaked at $51.6 million in Q1 2018 and troughed at -$28.2 million in Q3 2017.
  • A 3-year average of $4.5 million and a median of -$488542.9 in 2017 define the central range for Divestments.
  • On a YoY basis, Divestments climbed as much as 4380323.47% in 2019 and fell as far as 657627.82% in 2019.
  • Year by year, Divestments stood at -$28.2 million in 2017, then soared by 100.0% to $764.97 in 2018, then soared by 665236.8% to $5.1 million in 2019.
  • Business Quant data shows Divestments for MCUJF at $5.1 million in Q4 2019, -$5.0 million in Q3 2019, and $34.0 million in Q2 2019.